Literature DB >> 25632067

Letter to the editor concerning 'Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA'.

J Foglietta1, G Metro2, L Crinò2, S Gori3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25632067     DOI: 10.1093/annonc/mdv040

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.

Authors:  Vasileios Askoxylakis; Gino B Ferraro; David P Kodack; Mark Badeaux; Ram C Shankaraiah; Giorgio Seano; Jonas Kloepper; Trupti Vardam; John D Martin; Kamila Naxerova; Divya Bezwada; Xiaolong Qi; Martin K Selig; Elena Brachtel; Dan G Duda; Peigen Huang; Dai Fukumura; Jeffrey A Engelman; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2015-11-07       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.